Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Median Sales Estimate At $2.505


The EPS projection of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for quarter ended 2016-09-30 is $-1.57. Last week, the EPS forecast was $-1.57 against target of $-1.57, a month earlier. Two months ago, this estimate was $-1.57 versus forecast of $-1.57 three months earlier, implying a deviation of 0%.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.

In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 1, and 1, correspondingly.

EPS estimate downgrade for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in the preceding 30, 120, 60 and 90 days were 0, 2, 4, and 4, correspondingly.

Earnings Surprises

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EPS target for the quarter closed 1 was $-1.57, based on 9 recommendations. As reported on 2016-05-09 the EPS was $-1.35. The change was $-0.06, implying a percentage deviation of -4.65%. The projections showed a standard deviation of 0.15.

Quarterly Sales Estimates

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) yearly sales prediction for the fiscal 2016 stands at $2.505 and the median estimate is at $2.505. Almost 2 analysts issued sales target.

Highest sales target is $4.49 while the lowest target is $0.52 showing standard deviation of 2.807%.

As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.

Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.

A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced that the deviation in forecast was 0%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)